Cargando…

PI3K Functions in Cancer Progression, Anticancer Immunity and Immune Evasion by Tumors

The immunological surveillance of tumors relies on a specific recognition of cancer cells and their associate antigens by leucocytes of innate and adaptive immune responses. However, a dysregulated cytokine release can lead to, or be associated with, a failure in cell-cell recognition, thus, allowin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dituri, Francesco, Mazzocca, Antonio, Giannelli, Gianluigi, Antonaci, Salvatore
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2011
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3199188/ https://www.ncbi.nlm.nih.gov/pubmed/22046194 http://dx.doi.org/10.1155/2011/947858

Ejemplares similares

Tissue expression of Squamous Cellular Carcinoma Antigen (SCCA) is inversely correlated to tumor size in HCC
por: Trerotoli, Paolo, et al.
Publicado: (2009)

PI3K activation allows immune evasion by promoting an inhibitory myeloid tumor microenvironment
por: Collins, Natalie B, et al.
Publicado: (2022)

Sex-based dimorphism of anticancer immune response and molecular mechanisms of immune evasion
por: Conforti, Fabio, et al.
Publicado: (2021)

The Tumor Microenvironment Drives Intrahepatic Cholangiocarcinoma Progression
por: Mancarella, Serena, et al.
Publicado: (2022)

Validation of Hepatocellular Carcinoma Experimental Models for TGF-β Promoting Tumor Progression
por: Mancarella, Serena, et al.
Publicado: (2019)

Correction: Differential Inhibition of the TGF-β Signaling Pathway in HCC Cells Using the Small Molecule Inhibitor LY2157299 and the D10 Monoclonal Antibody against TGF-β Receptor Type II
por: Dituri, Francesco, et al.
Publicado: (2013)

Impaired Anti-Tumor T cell Response in Hepatocellular Carcinoma
por: Chaoul, Nada, et al.
Publicado: (2020)

Differential Inhibition of the TGF-β Signaling Pathway in HCC Cells Using the Small Molecule Inhibitor LY2157299 and the D10 Monoclonal Antibody against TGF-β Receptor Type II
por: Dituri, Francesco, et al.
Publicado: (2013)

Acetylation in Tumor Immune Evasion Regulation
por: Lu, Jun, et al.
Publicado: (2021)

Trajectory of immune evasion and cancer progression in hepatocellular carcinoma
por: Nguyen, Phuong H. D., et al.
Publicado: (2022)

Hypoxia-Regulated Tumor-Derived Exosomes and Tumor Progression: A Focus on Immune Evasion
por: Shao, Xuejun, et al.
Publicado: (2022)

Immune System Evasion as Hallmark of Melanoma Progression: The Role of Dendritic Cells
por: Tucci, Marco, et al.
Publicado: (2019)

Viral mechanisms of immune evasion
por: Alcami, Antonio, et al.
Publicado: (2000)

Viral mechanisms of immune evasion
por: Alcami, Antonio, et al.
Publicado: (2000)

Viral mechanisms of immune evasion
por: Alcami, Antonio, et al.
Publicado: (2000)

Porphyromonas gingivalis induction of TLR2 association with Vinculin enables PI3K activation and immune evasion
por: Pandi, Karthikeyan, et al.
Publicado: (2023)

Overcoming tumor immune evasion with an unique arbovirus
por: Lyday, Bruce, et al.
Publicado: (2015)

Immune Evasion Mechanisms of Entamoeba histolytica: Progression to Disease
por: Begum, Sharmin, et al.
Publicado: (2015)

Engineering immune evasion
por: Mascola, John R.
Publicado: (2006)

Transforming Growth Factor-β Promotes Morphomechanical Effects Involved in Epithelial to Mesenchymal Transition in Living Hepatocellular Carcinoma
por: Cascione, Mariafrancesca, et al.
Publicado: (2018)

The Interactivity between TGFβ and BMP Signaling in Organogenesis, Fibrosis, and Cancer
por: Dituri, Francesco, et al.
Publicado: (2019)

Laminin-332 γ2 Monomeric Chain Promotes Adhesion and Migration of Hepatocellular Carcinoma Cells
por: Scialpi, Rosanna, et al.
Publicado: (2023)

EMBR-33. YAP1 FUNCTION IN SHH MEDULLOBLASTOMA PROGRESSION AND IMMUNE EVASION
por: Abdelfattah, Nourhan, et al.
Publicado: (2021)

Cyclooxygenase-Dependent Tumor Growth through Evasion of Immunity
por: Zelenay, Santiago, et al.
Publicado: (2015)

Is CD47 an innate immune checkpoint for tumor evasion?
por: Liu, Xiaojuan, et al.
Publicado: (2017)

Interferon-Gamma at the Crossroads of Tumor Immune Surveillance or Evasion
por: Castro, Flávia, et al.
Publicado: (2018)

Cancer-Associated Fibroblasts: Accomplices in the Tumor Immune Evasion
por: Hilmi, Marc, et al.
Publicado: (2020)

TSH-TSHR axis promotes tumor immune evasion
por: Wu, Zhenghao, et al.
Publicado: (2022)

SNAIL1: Linking Tumor Metastasis to Immune Evasion
por: Tang, Xiaolong, et al.
Publicado: (2021)

Tumor microenvironment-mediated immune evasion in hepatocellular carcinoma
por: Chen, Chen, et al.
Publicado: (2023)

Peroxynitrite promotes immune evasion by reducing tumor antigenicity
por: Capietto, Aude-Hélène, et al.
Publicado: (2022)

HCC Heterogeneity: Molecular Pathogenesis and Clinical Implications
por: Fransvea, Emilia, et al.
Publicado: (2009)

Innate Immunity and Immune Evasion by Enterovirus 71
por: Pathinayake, Prabuddha S., et al.
Publicado: (2015)

Immune Evasion, Immunopathology and the Regulation of the Immune System
por: Sorci, Gabriele, et al.
Publicado: (2013)

Upregulated glycolysis correlates with tumor progression and immune evasion in head and neck squamous cell carcinoma
por: Takahashi, Hideyuki, et al.
Publicado: (2021)

Filoviral Immune Evasion Mechanisms
por: Ramanan, Parameshwaran, et al.
Publicado: (2011)

Unveiling tumor immune evasion mechanisms: abnormal expression of transporters on immune cells in the tumor microenvironment
por: Chen, Lu, et al.
Publicado: (2023)

Lymphoma: Immune Evasion Strategies
por: Upadhyay, Ranjan, et al.
Publicado: (2015)

Immune Evasion Strategies of Glioblastoma
por: Razavi, Seyed-Mostafa, et al.
Publicado: (2016)

Immune evasion mechanisms of arenaviruses
por: Ly, Hinh, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_3uarmfk11ens54ip7f77o5mo0s